Old Web
English
Sign In
Acemap
>
authorDetail
>
Tom Zanardi
Tom Zanardi
Isis Pharmaceuticals
Immunology
Phosphorylation
Cell biology
Spinal cord
Pathological
2
Papers
214
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
2017
Science Translational Medicine
Sarah L. DeVos
Rebecca L. Miller
Kathleen M. Schoch
Brandon B. Holmes
Carey S. Kebodeaux
Amy J. Wegener
Guo Chen
Tao Shen
Hien Tran
Brandon Nichols
Tom Zanardi
Holly Kordasiewicz
Eric E. Swayze
C. Frank Bennett
Marc I. Diamond
Timothy M. Miller
Show All
Source
Cite
Save
Citations (209)
Discovery and Early Clinical Development of ISIS-HTTRx, the First HTT-Lowering Drug to Be Tested in Patients with Huntington’s Disease (PL01.002)
2016
Neurology
Blair R. Leavitt
Sarah J. Tabrizi
Holly Kordasiewicz
Bernhard Landwehrmeyer
Scott P. Henry
Tom Zanardi
Eric E. Swayze
Daniel A. Norris
Anne Smith
Roger Lane
Frank C. Bennett
Show All
Source
Cite
Save
Citations (5)
1